MARKET WIRE NEWS

Pzena European Focused Value Q1 2025 Commentary

Source: SeekingAlpha

2025-05-27 11:20:00 ET

Summary

  • European markets were very strong to start 2025 buoyed by German stimulus actions and an investor rotation from U.S. to European equities amid the backdrop of U.S. equities’ rich valuations.
  • In this context, value materially outperformed and our portfolio lagged the MSCI Europe Index and MSCI Europe Value Index.
  • Even after the strong performance year-to-date, we continue to see good value in European equities as they trade at a notable valuation discount relative to the rest of the world.

Returns are in USD As of March 31, 2025

1Q 2025

YTD

One Year

Annualized Returns - Three Year

Annualized Returns - Five Year

Annualized Returns

Ten Year

Since Inception 8/1/2008

Pzena European Focused Value Composite — Gross

10.2%

10.2%

12.7%

10.7%

20.2%

6.4%

6.2%

Pzena European Focused Value Composite — Net

10.0%

10.0%

12.0%

10.0%

19.4%

5.7%

5.6%

MSCI Europe Index

10.5%

10.5%

6.9%

7.3%

13.2%

5.7%

4.2%

MSCI Europe Value Index

16.1%

16.1%

18.0%

11.1%

15.9%

5.0%

3.2%

Past performance is not indicative of future results. Periods greater than one year are annualized in USD.

Returns could be impacted, positively or negatively, by currency fluctuations, where applicable.

Gross rates of return are presented gross of investment management fees and net of the deduction of transaction costs. An investor’s actual return will be reduced by investment management fees. Net Returns are derived using a model fee applied monthly to Gross returns. Pzena uses the highest tier fee schedule, excluding performance fees, to illustrate the impact of fees on performance returns. As product fees change, the current highest tier schedule will be in effect.

Read the full article on Seeking Alpha

For further details see:

Pzena European Focused Value Q1 2025 Commentary
Sanofi

NASDAQ: SNY

SNY Trading

-0.79% G/L:

$44 Last:

1,995,467 Volume:

$43.66 Open:

mwn-app Ad 300

SNY Latest News

SNY Stock Data

$119,804,457,217
2,430,957,423
N/A
389
N/A
Pharmaceuticals
Healthcare
FR
Paris

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App